| CARVIEW |
Turning complex biomedical data into transformative insights
Products
We offer a range of rigorously developed products for precision medicine that empower your organization to generate valuable insights for drug development.
Pathology Foundation Models
Leverage our foundation models to generate embeddings for model training or develop custom downstream applications for your pathology workflows.
Aignostics Atlas Product Series
Atlas H&E-TME is a comprehensive tumor microenvironment profiling application that was built using our leading foundation model.
Services
We offer custom services for complex image and data analysis from early drug discovery through regulated clinical applications.
Target & Biomarker Discovery
Generate bespoke, multimodal datasets to holistically identify new drug targets and biomarkers.
Translational Research
Measure complex biomarkers and predict expression patterns accurately and scalably across data modalities.
Digital Diagnostics
Refine proof-of-concept models into validated, efficacious clinical tools for prospective use in the real world.
Enabling precision medicine for every patient
Our mission is to transform drug development and improve patient outcomes with AI that delivers novel insights for precision medicine.
Our mission is to transform drug development and improve patient outcomes with AI that delivers novel insights for precision medicine.
Proprietary access to multimodal data
We have access to pathology samples and multimodal data from over 30M patients at leading university hospitals
and laboratories.
We have access to pathology samples and multimodal data from over 30M patients at leading university hospitals
and laboratories.
Deep biomedical expertise
Our team of data scientists, machine learning engineers, pathologists and biologists provide expert input and oversight into all of our products and services.
Our team of data scientists, machine learning engineers, pathologists and biologists provide expert input and oversight into all of our products and services.
Advanced machine learning capabilities
Our machine learning approaches represent the frontier of AI - from industry-leading foundation models to advanced analytic techniques.
Our machine learning approaches represent the frontier of AI - from industry-leading foundation models to advanced analytic techniques.
Cutting-edge collaborations with academic partners
We’ve established deep research collaborations with leading academic institutions in the EU and US.
We’ve established deep research collaborations with leading academic institutions in the EU and US.
Products and Services
We relentlessly innovate to ensure our products and services support the evolving needs of precision medicine research.
We relentlessly innovate to ensure our products and services support the evolving needs of precision medicine research.
Interdisciplinary team with deep functional competency
Aignostics is a spin-off from Charité Berlin, one of Europe’s largest and most esteemed university hospitals. Today, our team has grown to include a diverse array of cross-functional experts working from our offices in Berlin and New York.
ISO 13485 and 27001 certified
GCP-ready clinical trial platform
Looking for an opportunity to work on something meaningful?
Join our diverse and fast-growing team to help revolutionize how cancer and other complex diseases are diagnosed and treated.
Case Studies
Anomaly Detection for Rare Diseases
This study discusses how our foundation model was applied to anomaly detection for rare diseases. Click below and fill out the form to see the full case study.
Enhanced Generalizability of Digital Pathology AI
This study discusses how our foundation model enhances the generalizability of a cell classification task. Click below and fill out the form to see the full case study.
Improved Performance and Label Efficiency
This study discusses how our foundation model improves downstream model performance and reduces the need for large training datasets. Click below and fill out the form to see the full case study.
